European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Linnaeus University · International Drug Development · +8 more institutions
Indexed incrossrefpubmed
Abstract
C-reactive protein CURE Clopidogrel in Unstable Angina to Prevent Recurrent Events CVD cardiovascular disease DALYs disability-adjusted life years DBP diastolic blood
Citation impact
8,515
total citations
- FWCI
- 431.34
- Percentile
- 100%
- References
- 869
Citations per year
Authors
87- AFAuthors/Task Force Members:Corresponding
Linnaeus University, International Drug Development
- JPJoep Perk
Linnaeus University, European Society of Cardiology
- GDGuy De Backer
European Society of Cardiology
- HGH. Gohlke
European Society of Cardiology
- IGIan Graham
European Atherosclerosis Society
Topics & keywords
Topics
Keywords
- Medicine
- Clinical Practice
- Task force
- Disease
- Clopidogrel
- Angina
- Intensive care medicine
- Cardiovascular health
No related works found for this paper.